Rapid determination of the anti-cancer drug chlorambucil (Leukeran™) and its phenyl acetic acid mustard metabolite in human serum and plasma by automated solid-phase extraction and liquid chromatography–tandem mass spectrometry
- 8 September 1999
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 732 (1) , 173-184
- https://doi.org/10.1016/s0378-4347(99)00280-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Determination of chlorambucil in plasma using reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Studies on the quantitation of chlorambucil in plasma by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Inhibition of human tumour clonogenicity by chlorambucil and its metabolitesBritish Journal of Cancer, 1982
- Kinetics of Chlorambucil Hydrolysis Using High-Pressure Liquid ChromatographyJournal of Pharmaceutical Sciences, 1982
- The metabolism of chlorambucilBiochemical Pharmacology, 1980
- Mass Spectrometry of Chlorambucil, its Degradation Products, and its Metabolite in Biological SamplesJournal of Pharmaceutical Sciences, 1980
- Estimation of chlorambucil, phenyl acetic mustard and prednimustine in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1979
- Pharmacokinetics and metabolism of chlorambucil in man: a preliminary reportCancer Treatment Reviews, 1979
- Pharmacokinetics of chlorambucil in ovarian carcinoma using a new HPLC assayBiochemical Pharmacology, 1979
- Chlorambucil Therapy for Lymphomas and Chronic Lymphocytic LeukemiaJAMA, 1965